Which Anti-Snoring Devices You Can Buy Yourself in Europe and Which Ones Need a Prescription First

Which Anti-Snoring Devices You Can Buy Yourself in Europe and Which On - Back2Sleep

Anti-Snoring Device Prescription Rules in Europe Mapped by Category, Country and Payer

Most anti-snoring devices in Europe are ordinary consumer purchases, four categories are not, and the paperwork changes at every EU border.

AI-assisted writing

Anti-Snoring Device Prescription Rules in Europe, Answered in 60 Seconds

Most anti-snoring devices sold in Europe need no prescription. Nasal strips, external and internal nasal dilators, mouth tape, boil-and-bite mouthpieces and positional therapy belts are ordinary consumer purchases. The anti-snoring device prescription rules in Europe bite on four categories only: CPAP and its variants, custom-made mandibular advancement devices, hypoglossal nerve stimulation and surgery. Those need a clinician, and usually a sleep study, before anyone supplies one.

The confusion comes from a mix-up almost nobody explains. CE marking decides whether a device may legally be placed on the EU market. Prescription status is a separate clinical gate. National reimbursement is a third gate again. A device can be CE-marked, freely sold, and still worth nothing to your insurer. If you are comparing categories rather than shopping, our breakdown of treatment options for mild to moderate sleep apnoea explains what each one physically does.

Key Takeaway
  • No prescription needed: nasal strips, nasal dilators and stents, mouth tape, positional belts, boil-and-bite and most semi-custom mouthpieces.
  • Clinician-gated: CPAP, APAP and BiPAP, custom oral appliances, upper airway stimulation, surgery.
  • CE-marked never means clinically assessed for you, and it never means reimbursed.
Infographic about Which Anti-Snoring Devices You Can Buy Yourself in Europe an

Two Things Most Anti-Snoring Device Prescription Guides Get Wrong

The first flaw is the tier model. English-language guides teach that boil-and-bite and semi-custom appliances are free to buy while custom ones need a prescription. That is an American construct. In France and Germany the gate is not how the device is fabricated. It is who signs for it.

The second flaw is treatment order. Most guides teach CPAP first, oral appliance only if you fail. France inverts that. Assurance Maladie states that the orthèse d'avancée mandibulaire (OAM) doit etre proposee en premiere intention dans les Sahos moderes, meaning an apnoea-hypopnoea index (AHI) between 15 and 30 events per hour, with CPAP refusal or intolerance handled second-line above that band. The UK sits somewhere else again. NICE guideline NG202 recommends a customised or semi-customised mandibular advancement splint at all levels of severity for people who decline or cannot tolerate CPAP, according to the Sleep Apnoea Trust leaflet on NG202 (2021).

A third habit is worth naming. Almost every English-language guide on this question ends the same way: ask your dentist. In the EU that sentence points at the wrong door. A dentist practising dental sleep medicine fabricates and fits the appliance, but in France and Germany a qualified physician stands in front of that step, and it is the physician who reads your sleep study.

Key Takeaway
  • Custom versus semi-custom is a US gate, not a European one.
  • France offers oral appliances first-line at an AHI of 15 to 30; the UK allows them at any severity after CPAP intolerance.
  • The dentist builds the device. The physician opens the door.
Back2Sleep nasal stent vs other anti-snoring devices

CE Marking Is Market Access, Not a Prescription

A CE mark means the manufacturer has declared the device compliant with EU Regulation 2017/745, the Medical Device Regulation. It is a market-access statement. It is not a clinical recommendation, not an approval of your treatment plan, and not a payer decision. That single distinction explains most anti-snoring device prescription confusion in Europe.

Why the same mouthpiece is gated on one site and not another

Under Annex VIII of EU MDR 2017/745, a manufacturer self-classifies its device against 22 rules, and guidance document MDCG 2021-24 confirms that the strictest applicable rule determines the class. A device marketed for simple snoring can be self-declared Class I with no notified body involvement at all. The same hardware, marketed to treat obstructive sleep apnoea, moves up a class and picks up external assessment. That self-certification route, not clinical logic, is why an identical-looking appliance appears freely purchasable on one European storefront and clinician-gated on another.

How to check a CE claim before you pay

EUDAMED, the European Commission database, holds a living record of devices made available in the European Union. You can look up a device's UDI-DI or Basic UDI-DI in a few minutes at ec.europa.eu/tools/eudamed. Do that before paying a cross-border seller. US review sites check products against American market clearance instead, which carries no weight for a purchase made in Lyon, Leipzig or Leeds.

Switzerland sits outside this system. Swiss devices are registered with Swissmedic alongside CE and ISO 13485 certification, so "CE marked" and "legally on sale in Switzerland" are two different statements. Swiss and French reimbursement conditions for custom-made orthoses also differ from each other.
Key Takeaway
  • CE marking answers "may this be sold here", never "should you use this".
  • Class I devices are self-declared, with no notified body check.
  • Verify a UDI-DI in EUDAMED before buying from an unfamiliar EU seller.
Choose Your Size →

The Full Map of Anti-Snoring Device Prescription Status Across Europe

Anti-snoring device prescription status in Europe splits by category, not by price. The table below maps each treatment class against the gate that actually blocks it, and against what a payer will ask for afterwards.

Category Buy it yourself in the EU Who gates it Reimbursement gate
Nasal strips, external dilators Yes Nobody None, out of pocket
Internal nasal stent Yes Nobody None, out of pocket
Mouth tape Yes Nobody None, out of pocket
Nasal EPAP valve Varies by seller Seller policy, and the claim the maker registers None in most member states
Boil-and-bite or semi-custom appliance Yes Seller policy only FR and DE: no cover if bought online
Custom OAM, UKPS or MAS No Physician's ordonnance or Verordnung, dentist fabricates FR: prior authorisation. DE: specialist Verordnung
Positional therapy device Yes Nobody Reimbursed in the Netherlands after a ZIN recommendation
CPAP, APAP, BiPAP (PPC) No in practice Sleep study, diagnosis, pressure setting, retailer policy FR: prior authorisation. UK: NHS referral or private route
Hypoglossal nerve stimulation Not a purchase at all Hospital referral, sleep endoscopy, team decision Hospital pathway only
Surgery: uvulopalatopharyngoplasty (UPPP), septoplasty, turbinate reduction No ENT surgeon Hospital pathway only

Two rows deserve a note. A nasal EPAP valve, short for expiratory positive airway pressure, works on the out-breath: it adds resistance as you exhale, which pressurises the airway from inside. An internal nasal stent works mechanically and continuously, holding the nasal airway physically open along its length. Same nostril, different physics, and neither category is prescription-gated in most of the EU.

Upper airway stimulation is the row people misread most. It is not a device you are refused permission to buy. It is implanted surgery, entered through a hospital referral, with drug-induced sleep endoscopy and a multidisciplinary decision along the way. Published UK eligibility information for upper airway stimulation describes a window of 15 to 65 events per hour, so most simple snorers fall well outside it.

Key Takeaway
  • Five of the ten categories above carry no clinician gate at all.
  • Custom appliances and PAP therapy are the two real prescription walls.
  • Stimulation and surgery are referral pathways, not purchases.
Back2Sleep product engineered for nasal airway support

Country by Country: France, Germany, the UK and the Netherlands

Anti-snoring device prescription rules in Europe are national, not European. The device travels freely. The paperwork does not.

France

Both PPC (pression positive continue, the French name for CPAP) and the OAM are subject to a demande d'accord préalable (DAP) to Assurance Maladie, filed through the amelipro teleservice for patients aged 16 and over. The prescriber uses Cnam model form Ref. 634, in force since 15 June 2018. Since 31 December 2024, practitioners equipped with amelipro must also meet electronic prescription requirements under Decret 2023-1222. The prescriber must be a physician, typically a pneumologist or another sleep physician, holding a DES covering sleep respiratory disorders, validated continuous professional development in sommeil, or a recognised sleep pathology diploma. Prior authorisation can be refused, and that answer, not your purchase, decides whether you pay nothing or several hundred euros. Our guide to Sécurité Sociale and mutuelle cover for sleep apnoea walks through the sequence in order.

Germany

The G-BA added the Unterkieferprotrusionsschiene to the statutory benefit catalogue by decision of 20 November 2020, with the implementing Behandlungsrichtlinie decision dated 6 May 2021 and effective from 30 July 2021. It covers adults with obstructive sleep apnoea in whom positive-pressure therapy has failed. German patients usually ask whether they need a Rezept. The operative document is narrower than that: you receive the splint as a covered service only with a specialist physician's Verordnung, after which the Zahnarzt bills the gesetzliche Krankenversicherung directly. No Verordnung, no cover, and the splint becomes a private purchase.

United Kingdom

A CPAP is a CE or UKCA-marked Class IIa medical device, Class IIb for bilevel. It is not a prescription-only medicine, so no UK law forbids selling one. What blocks the sale is the retailer's own supply policy: a valid sleep study report from a qualified clinical provider, NHS or private, a confirmed diagnosis and ideally a recommended pressure setting. A consumer smartwatch reading does not satisfy that. US-focused pages say the opposite because American rules do require a prescription for CPAP sale there, and those rules govern nothing about a purchase made in Britain.

Netherlands

Positional therapy is a payer-recognised category here, not a gadget. A positional therapy device for positional OSA (POSA) obtained national reimbursement after a positive recommendation from Zorginstituut Nederland (ZIN) and formal approval by the Ministry of Health, Welfare and Sport. A Dutch reader filing positional devices under "consumer accessories" is leaving cover on the table.

Terminology costs people their own pathway. SAHOS and OAM in France, OSAHS and MAS in the UK, Unterkieferprotrusionsschiene in Germany, MAD in American English. Search the American term and you land on an American page that never mentions the DAP or the G-BA route that actually applies to you.
Key Takeaway
  • France gates on prior authorisation, filed before purchase, on a specific Cnam form.
  • Germany gates on a specialist physician's Verordnung, with the dentist billing afterwards.
  • The UK gates on retailer supply policy and a sleep study report, not on law.
  • The Netherlands reimburses positional therapy that other countries treat as a gadget.

Do You Need a Sleep Study Before You Buy

You need a sleep study for CPAP, custom oral appliances, stimulation and surgery. You do not need one to buy a nasal dilator, a nasal stent, mouth tape or a positional belt. What the study gives you is the number that decides everything downstream: your apnoea-hypopnoea index, plus an oxygen desaturation index and an Epworth Sleepiness Scale score.

936M
Adults aged 30-69 with OSA worldwide, Lancet Respiratory Medicine 2019
425M
Of those, moderate-to-severe at AHI 15 or above, same 2019 analysis
-30.7/h
AHI reduction with CPAP, EClinicalMedicine umbrella review 2025
-11.91/h
AHI reduction with a mandibular advancement device, same 2025 review

Benjafield and colleagues, writing in The Lancet Respiratory Medicine in 2019, estimated 936 million adults aged 30 to 69 with mild-to-severe obstructive sleep apnoea and 425 million at moderate-to-severe level. Diagnosed numbers are climbing fast in Europe. Clinically diagnosed OSA incidence in Finland rose from 1.7 to 6.1 per 1,000 between 2010 and 2020, reported in the European Journal of Public Health in 2026.

NICE guideline NG202 (2021) sets the severity bands that route UK patients: mild at an AHI of 5 to 14, moderate at 15 to 30, severe above 30. Those thresholds matter more than any product page, because national pathways key off them. Assurance Maladie makes the OAM first-line at an IAH of 15 to 30. Above 30, no self-purchased device is an adequate answer.

Getting tested, in order

  1. Screen yourself with a validated questionnaire such as the Epworth Sleepiness Scale.
  2. Book the GP or generalist appointment and describe witnessed pauses, choking arousals and daytime sleepiness explicitly.
  3. Accept whichever test is offered: a home sleep apnoea test, a polygraphie ventilatoire nocturne, or full in-lab polysomnography.
  4. Ask for your AHI and oxygen desaturation index in writing, not just a summary sentence.
  5. Only then choose a treatment category, because that number decides which ones are open to you.

Waiting is the real problem. NHS England publishes sleep-study waits within its DM01 diagnostic reporting, and health-service journalism has described patients waiting close to a year for a study before recent pilot schemes, while private routes are measured in days. That gap is exactly why the no-prescription column of the table above matters.

Key Takeaway
  • No test is needed to buy a consumer device; a test is needed to be treated properly.
  • AHI bands: 5-14 mild, 15-30 moderate, above 30 severe, per NICE NG202 (2021).
  • Get the raw numbers in writing, since every national pathway keys off them.
Try Back2Sleep Tonight →

A Four-Step Route If CPAP Has Already Failed You

CPAP intolerance is where the European pathways diverge, and the answer is a sequence rather than a product. Here is the order that fits the anti-snoring device prescription rules in Europe.

1Get the intolerance documented

Both the French second-line OAM route and the German Unterkieferprotrusionsschiene benefit are built on documented positive-pressure failure or refusal. An undocumented abandonment closes both doors. Tell your prescriber precisely why you stopped, and ask for it in the file.

2Ask about an oral appliance on the national route

The evidence is better than most people assume. In the CHOICE multicentre randomised trial published in the European Respiratory Journal in 2025, mandibular advancement splints achieved higher nightly adherence than CPAP, 6.0 against 5.3 hours, while CPAP remained more efficacious by 10.4 events per hour. The authors concluded that both showed comparable clinical effectiveness on patient-centred outcomes, and 55% of participants chose to alternate between the two therapies.

3Use the no-prescription column as a bridge, not a substitute

While a referral, a DAP or a Verordnung moves through the system, a CE-marked device you can buy today is a defensible interim step. The Back2Sleep nasal stent belongs in that column: a CE-certified Class I soft silicone intranasal device that holds the nasal airway open during sleep, sold without prescription across Europe in a starter kit of four sizes. If you want the purchase logistics, we compare buying a nasal stent online against pharmacy channels separately.

4Escalate if the numbers say so

If your AHI sits above 30, if you have witnessed apnoeas with choking arousals, or if you fall asleep driving, no self-purchased device is the answer. That is a hospital conversation about surgery, upper airway stimulation or a different PAP interface.

Availability is a regulatory fact, not a clinical clearance. A device you can add to a basket has not been assessed for your airway. Free availability and clinical suitability are unrelated in EU law.
Key Takeaway
  • Document positive-pressure intolerance formally, or the national second-line routes stay shut.
  • Oral appliance adherence beat CPAP adherence in a 2025 European Respiratory Journal trial.
  • A no-prescription device bridges a waiting list; it does not replace a diagnosis.
Infographic about Which Anti-Snoring Devices You Can Buy Yourself in Europe an

What Back2Sleep Users Say

★★★★★
"After reading some comments, I was worried the product wouldn't meet my expectations. But after a few days of adaptation, the product is very effective — no more snoring for me at all."
— Stéphane G. Verified Amazon Purchase
★★★★★
"I tried several devices — nasal dilators, mandibular advancement splints, jaw blockers. After my first night with Back2Sleep, the effect was spectacular. I didn't snore at all, which is exceptional for me. I felt like I finally breathed through my nose properly. I'm currently using a CPAP machine, and I can say Back2Sleep is more effective. The slight discomfort in the throat goes away after a few nights. I highly recommend this device."
— Benjamin Verified Amazon Purchase
★★★★☆
"Day 1: The tube is easy to insert but it made me feel nauseous. Day 2: I managed with the shortest tube and felt better. Days 3-4: I moved to size M and got used to the feeling in my throat. I woke up and I wasn't tired! No more heavy legs or fatigue. Tonight I'm trying size L."
— Greg Verified Amazon Purchase

Frequently Asked Questions

Do you need a prescription to buy a CPAP machine in Europe?

In the UK, no law makes CPAP a prescription-only medicine, since it is a CE or UKCA-marked Class IIa device, Class IIb for bilevel. What blocks the sale is the retailer's supply policy: a sleep study report from a qualified clinical provider, a confirmed diagnosis and ideally a recommended pressure setting. Consumer sleep trackers do not qualify.

Can I buy an anti-snoring mouthpiece without seeing a dentist?

Yes, for boil-and-bite and most semi-custom mouthpieces, which are sold directly across the EU with no clinician involved. Custom appliances are different. In France a sleep-trained physician must prescribe first, and in Germany statutory cover requires a specialist physician's Verordnung before the dentist fabricates, fits or bills for the splint.

Which anti-snoring devices can I buy over the counter in the EU?

Nasal strips, external nasal dilators, internal nasal stents, mouth tape, boil-and-bite and most semi-custom mouthpieces, and positional therapy belts are all bought directly, with no prescription. Nasal EPAP valves vary by seller. Availability is a regulatory fact rather than a clinical clearance, so screen yourself for red-flag symptoms first.

Do I need a sleep study before I can buy an anti-snoring device?

Not for consumer devices such as nasal strips, nasal stents, mouth tape or positional belts. You do need one for CPAP, custom oral appliances, nerve stimulation and surgery. A study also gives you your apnoea-hypopnoea index, the number that decides which national pathway and which reimbursement rules apply to you.

Is a CE-marked anti-snoring device the same as an approved or prescribed one?

No. CE marking under EU MDR 2017/745 means a device may legally be placed on the EU market. Class I devices are self-declared by the manufacturer with no notified body involved. It says nothing about whether the device suits your apnoea-hypopnoea index, and nothing about whether any payer will reimburse it.

Does an orthèse d'avancée mandibulaire need an ordonnance and a demande d'accord préalable in France?

Yes to both. A physician with recognised sleep training writes the prescription on Cnam model form Ref. 634, in force since 15 June 2018, then files a demande d'accord préalable through the amelipro teleservice. Assurance Maladie can refuse it, and that answer decides whether you pay nothing or several hundred euros.

Does the German Krankenkasse pay for an Unterkieferprotrusionsschiene, and do you need a Rezept?

The G-BA added the Unterkieferprotrusionsschiene to the statutory benefit catalogue by decision of 20 November 2020, effective 30 July 2021, for adults whose positive-pressure therapy has failed. Cover requires a specialist physician's Verordnung; the Zahnarzt then bills the Krankenkasse. Without that Verordnung the splint is a private purchase.

Medical Disclaimer: This article is for informational purposes only and does not replace professional medical advice. Snoring can be a symptom of obstructive sleep apnea, a serious medical condition. If you suspect sleep apnea, consult a healthcare professional. Back2Sleep is a CE-certified Class I medical device intended for the treatment of snoring and mild to moderate sleep apnea.

Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.

Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.

Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.

Back to blog